Drug Database
Back to search

Belgium· BE-AMP-SAM168567-00

Neurolite

A technetium (99mtc) bicisate product containing bicisate dihydrochloride, registered in Belgium by Lantheus EU. The same ATC class is registered in 3 of our 19 countries.

ATC V09AA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNeuroliteATCV09AA02REGISTER NO.BE-AMP-SAM168567-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bicisate dihydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Technetium (99mtc) bicisate is registered in 3 of 19 countries.

Countries holding a registration under ATC V09AA02 (technetium (99mtc) bicisate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose
Search technetium (99mtc) bicisate products by name

Technetium (99mtc) bicisate · ATC V09AA02

3 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Bicisate Dihydrochloride
Manufacturer
Lantheus EU
Country
Belgium (BE)
ATC code
V09AA02
ATC class
Technetium (99mTc) bicisate
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3338183

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Technetium (99mtc) bicisate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All technetium (99mtc) bicisate products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Luxembourg · Neurolite

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3a10b43-95b4-4156-8c89-59bf41fcaffa
GET /v1/drugs/d3a10b43-95b4-4156-8c89-59bf41fcaffa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit for radiopharmaceutical preparation",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Neurolite",
  "name_fr": "Neurolite",
  "name_nl": "Neurolite",
  "amp_code": "SAM168567-00",
  "strengths": [
    "0.9000",
    "0.3600",
    "4.1000",
    "34.0000",
    "0.4600"
  ],
  "pack_count": 1,
  "substances": [
    "Bicisate Dihydrochloride",
    "Disodium Edetate",
    "Disodium Hydrogen Phosphate Heptahydrate",
    "Mannitol",
    "Sodium Dihydrogen Phosphate Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Technetium (99mTc) Bicisate",
  "authorisation_numbers": [
    "BE168567"
  ]
}
API referenceMCP serverPlans

See everything about technetium (99mtc) bicisate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console